SCN1A and Dravet syndrome: Moreover, the consequences we have shown of increased Scn1a expression point to the need for quantitative precision in genetic therapies intended to increase SCN1A transcription [10] for treatment of seizures in Dravet syndrome associated with SCN1A haploinsufficiency.